Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma

Annals of Hematology

Volumn 91, Issue 8, 2012, Pages 1265-1270

  Li, Zhi Ming ^a   Zhu, Ying Jie ^a   Sun, Jian ^a   Xia, Yi ^a   Huang, Jia Jia ^a   Zou, Ben Yan ^a   Lin, Tong Yu ^a   Huang, Hui Qiang ^a   Jiang, Wen Qi ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Beta2 microglobulin; Prognosis; Upper aerodigestive tract NK T cell lymphoma

Indexed keywords

ASPARAGINASE; BETA 2 MICROGLOBULIN; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; LACTATE DEHYDROGENASE; METHOTREXATE; OXALIPLATIN; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ANN ARBOR STAGE; ARTICLE; BONE MARROW METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; HUMAN TISSUE; INTERNATIONAL PROGNOSTIC INDEX SCORE; KOREAN PROGNOSTIC INDEX SCORE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NK T CELL LYMPHOMA; NOSE CAVITY CANCER; OROPHARYNX CANCER; OVERALL SURVIVAL; PARANASAL SINUS CANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL RATE; SYMPTOM; UPPER AERODIGESTIVE TRACT NK T CELL LYMPHOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA 2-MICROGLOBULIN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84865000830     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1434-1     Document Type: Article

References (27)

1. Lee J, Suh C, Park YH et al (2006) Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 24:612-618 (Pubitemid 46630424)
2. Sabattini E, Bacci F, Sagramoso C et al (2010) WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 102:83-87
3. Vose J, Armitage J, Weisenburger D (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26:4124-4130
4. Au WY, Ma SY, Chim CS et al (2005) Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. AnnOncol 16:206-214
5. Au WY, Weisenburger DD, Intragumtornchai T et al (2009) International Peripheral T-Cell Lymphoma Project. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 113:3931-3937
6. Kim TM, Park YH, Lee SY et al (2005) Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type. Blood 106:3785-3790
7. Lee J, Kim WS, Park YH et al (2005) Nasal-type NK/T cell lymphoma: clinical features and treatment outcome. Br J Cancer 92:1226-1230 (Pubitemid 40604396)
8. Lee J, Park YH, Kim WS et al (2005) Extranodal nasal type NK/Tcell lymphoma: elucidating clinical prognostic factors for riskbased stratification of therapy. Eur J Cancer 41:1402-1408 (Pubitemid 40826463)
9. Chim CS, Ma SY, Au WY et al (2004) Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 103:216-221
10. You JY, Chi KH, Yang MH et al (2004) Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol 15:618-625
11. Huang JJ, Jiang WQ, Lin TY et al (2011) Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/Tcell lymphoma, nasal type. Ann Oncol 22:149-155
12. Kim HS, Kim KH, Kim KH et al (2009) Whole blood Epstein- Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma. Leuk Lymphoma 50:757-763
13. Martayan A, Sibilio L, Tremante E et al (2009) Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells. J Immunol 182:3609-3617
14. Bouvier M (2003) Accessory proteins and the assembly of human class I MHC molecules: a molecular and structural perspective. Mol Immunol 39:697-706 (Pubitemid 36078363)
15. Munshi NC, Anderson KC, Bergsagel PL et al (2011) Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2. Blood 117:4696-4700
16. Dimopoulos M, Kyle R, Fermand JP et al (2011) Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3. Blood 117:4701-4705
17. Antic D, Mihaljevic B, Cokic V et al (2011) Patients with early stage chronic lymphocytic leukemia: new risk stratification based on molecular profiling. Leuk Lymphoma 52:1394-1397
18. Chronowski GM, Wilder RB, Tucker SL et al (2002) An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease. Cancer 95:2534-2538 (Pubitemid 35424039)
19. Federico M, Bellei M, Marcheselli L et al (2009) Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol 27:4555-4562
20. Federico M, Guglielmi C, Luminari S et al (2007) Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. Haematologica 92:1482-1488 (Pubitemid 350144123)
21. Rodríguez J, Conde E, Gutiérrez A et al (2007) The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma. Haematologica 92:1067-1074 (Pubitemid 350144213)
22. Moore DF Jr, Cabanillas F (1998) Overview of prognostic factors in non-Hodgkin's lymphoma. Oncology (Williston Park) 12:17-24 (Pubitemid 128637450)
23. Cheson BD, Horning SJ, Coiffier B et al (1999) Report of an international workshop to standardize response criteria for non- Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17:1244
24. Pagano L, Gallamini A, Trapè G et al (2006) NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey. Ann Oncol 17:794-800
25. Suki S, Swan F Jr, Tucker S et al (1995) Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase. Leuk Lymphoma 18:87-92
26. Huang WC, Wu D, Xie Z et al (2006) beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis. Cancer Res 66:9108-9116 (Pubitemid 44521130)
27. Nomura T, Huang WC, Seo S et al (2007) Targeting beta2- microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma. J Urol 178:292-300 (Pubitemid 46898459)